Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
PetIQ, Inc. PETQ
$12.86
-$0.24 (-1.83%)
На 18:00, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
388531502.00000000
-
week52high
18.42
-
week52low
6.66
-
Revenue
921513000
-
P/E TTM
-7
-
Beta
1.95190300
-
EPS
-1.65000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 20:00
Описание компании
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at 2,900 community clinics and wellness centers hosted at pet retailers across 42 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through approximately 60,000 points of distribution across veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Raymond James | Outperform | Outperform | 10 авг 2022 г. |
| Raymond James | Outperform | Outperform | 03 мар 2022 г. |
| Benchmark | Buy | 30 ноя 2021 г. | |
| Raymond James | Outperform | Outperform | 04 ноя 2021 г. |
| Raymond James | Outperform | Outperform | 26 февр 2021 г. |
| Raymond James | Outperform | Outperform | 25 окт 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Glasman Zvi | D | 27385 | 9128 | 03 янв 2023 г. |
| Glasman Zvi | D | 13809 | 5119 | 03 янв 2023 г. |
| Glasman Zvi | A | 18928 | 9128 | 03 янв 2023 г. |
| Herrman Robert Michael | A | 9050 | 1376 | 07 сент 2022 г. |
| Smith Michael A | A | 38155 | 10000 | 06 сент 2022 г. |
| Huff Scott | D | 0 | 480 | 09 авг 2022 г. |
| Huff Scott | A | 6753 | 480 | 09 авг 2022 г. |
| FIRST MARK L | D | 0 | 2245 | 29 июн 2022 г. |
| FIRST MARK L | A | 7106 | 2245 | 29 июн 2022 г. |
| Oloughlin Sheryl | D | 0 | 2245 | 29 июн 2022 г. |
Новостная лента
PetIQ, Inc. to Report First Quarter 2023 Financial Results on Tuesday, May 9, 2023
GlobeNewsWire
18 апр 2023 г. в 16:30
EAGLE, Idaho, April 18, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the first quarter ended March 31, 2023, on Tuesday, May 9, 2023, after the market close.
PetIQ Is A Bet On Steady Trends
Seeking Alpha
11 мар 2023 г. в 07:33
PetIQ is a company operating in a very large market, the pet care and health industry; a market that will see little in the way of slowing down. The earnings came in according to estimates and production was up too, but in the short term, there might be headwinds as inflation bites down on consumer spending.
PetIQ, Inc. (PETQ) Q4 2022 Earnings Call Transcript
Seeking Alpha
28 февр 2023 г. в 22:59
PetIQ, Inc. (NASDAQ:PETQ ) Q4 2022 Earnings Conference Call February 28, 2023 4:30 PM ET Company Participants Katie Turner - Investor Relations McCord Christensen - Chairman & Chief Executive Officer Zvi Glasman - Chief Financial Officer Michael Smith - President & Chief Operating Officer Conference Call Participants Bill Chappell - Truist Securities Corey Grady - Jefferies Rupesh Parikh - Oppenheimer Jon Andersen - William Blair Elliot Wilbur - Raymond James John Lawrence - Benchmark Operator Good day, and welcome to the PetIQ, Inc. Fourth Quarter and Full Year 2022 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.
PetIQ (PETQ) Reports Q4 Loss, Misses Revenue Estimates
Zacks Investment Research
28 февр 2023 г. в 21:50
PetIQ (PETQ) delivered earnings and revenue surprises of 37.50% and 4.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
PetIQ, Inc. to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 28, 2023
GlobeNewsWire
31 янв 2023 г. в 16:05
EAGLE, Idaho, Jan. 31, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the fourth quarter and full year ended December 31, 2022, on Tuesday, February 28, 2023, after the market close.